Inter-epidemic seroprevalence of Rift Valley fever virus and associated risk factors in humans in Eastern Rwanda
PLOS Neglected Tropical Diseases · 2025
DOI: 10.1371/journal.pntd.0013405 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Isidore Nsengimana und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Parasitology and Biotechnology, Sokoine University of Agriculture, Morogoro, Tanzania. Hauptthemen laut MEDLINE: Rift Valley Fever, Rift Valley fever virus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: USDA National Institute of Food and Agriculture, Regional Scholarship and Innovation Fund (RSIF) of the African Partnership for Skills in Applied Sciences, Engineering and Technology, National Institute of Food and Agriculture.
Abstract (Originalsprache)
Background
Rift Valley fever (RVF) is a mosquito-borne zoonosis that causes periodic and explosive epizootics/epidemics in Africa and the Arabian Peninsula. In Rwanda, RVF virus (RVFV) circulation has resulted into two major outbreaks in 2018 and 2022, both of which involving humans. Information on the magnitude of human exposure to RVFV in the country is scarce. This cross-sectional study aimed to investigate the seroprevalence of RVFV and associated risk factors in humans in the Eastern province of Rwanda, 3 years after the end of the 2018 outbreak. Methodology A total of 552 outpatients at health facilities in five districts of the Eastern province were randomly sampled and interviewed between December 2021 and February 2022. Exposure to RVFV was examined by detection of anti-RVFV IgG/IgM antibodies in serum samples using a competitive enzyme linked immunosorbent assay (c-ELISA). Bivariate and multivariate logistic regressions were used to assess the association between risk factors and RVFV seropositivity.
Results
The findings revealed an overall seroprevalence of 9.6%. The highest seropositivity, but without significant difference, was observed in Bugesera district (12.9%), followed by Kayonza, (10.8%), Kirehe (8.6%), Rwamagana (7.0%) and Ngoma (6.8%). Odds of seropositivity were significantly higher in people with a history of slaughtering animals (OR 2.26, 95% CI 1.04 - 4.91, p = 0.03), and milking (OR 2.60, 95% CI 1.23 - 5.49, p = 0.012). Sex and age-related differences were not significant.
Conclusion
This study is a first serological survey of RVFV spillover to humans in the country and shows that rural communities in Rwanda have been exposed to RVFV. These findings suggest the Eastern province of Rwanda as a potential hotspot for RVFV circulation, and emphasize the need for a countrywide One Health-based surveillance, prevention, and control strategy to minimize the effects of RVFV in the country.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Parasitology and Biotechnology, Sokoine University of Agriculture, Morogoro, Tanzania.
- SACIDS Africa Centre of Excellence for Infectious Diseases, SACIDS Foundation for One Health, Sokoine University of Agriculture, Morogoro, Tanzania.
- Rwanda Inspectorate, Competition and Consumer Protection Authority, Kigali, Rwanda.
- Laboratory of Emerging Infectious Diseases, Department of Microbiology and Immunology, Department of Pediatrics IWK, Faculty of Medicine, The Canadian Centre for Vaccinology, Dalhousie University, Halifax, Canada.
- Department of Animal Resource Research and Technology Transfer, Rwanda Agriculture and Animal Resources Development Board (RAB), Huye, Rwanda.
- Rwanda Biomedical Center (RBC), Ministry of Health, Kigali, Rwanda.
ORCID-Profile: Isidore Nsengimana
Förderung
- USDA National Institute of Food and Agriculture
- Regional Scholarship and Innovation Fund (RSIF) of the African Partnership for Skills in Applied Sciences, Engineering and Technology
- National Institute of Food and Agriculture
- Canadian Institutes of Health Research
- Research Nova Scotia
Zitieren
APA
Nsengimana, I., Kelvin, D., Uwibambe, E., Rwagasore, E., Muvunyi, C. M., Eastwood, G., Chengula, A. A., & Kasanga, C. J. (2025). Inter-epidemic seroprevalence of Rift Valley fever virus and associated risk factors in humans in Eastern Rwanda. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013405
Vancouver
Nsengimana I, Kelvin D, Uwibambe E, Rwagasore E, Muvunyi CM, Eastwood G, et al. Inter-epidemic seroprevalence of Rift Valley fever virus and associated risk factors in humans in Eastern Rwanda. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0013405
BibTeX
@article{Nsengimana2025,
author = {Nsengimana, Isidore and Kelvin, David and Uwibambe, Evodie and Rwagasore, Edson and Muvunyi, Claude M and Eastwood, Gillian and Chengula, Augustino A and Kasanga, Christopher J},
title = {Inter-epidemic seroprevalence of Rift Valley fever virus and associated risk factors in humans in Eastern Rwanda},
journal = {PLOS Neglected Tropical Diseases},
year = {2025},
doi = {10.1371/journal.pntd.0013405}
}
EUVIMED